Details for Patent: 8,778,366

« Back to Dashboard

Which drugs does patent 8,778,366 protect, and when does it expire?

Patent 8,778,366 protects EPANED KIT and is included in one NDA.

This patent has five patent family members in five countries.

Summary for Patent: 8,778,366

Title:	Enalapril compositions
Abstract:	Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
Inventor(s):	Lian G. Rajewski, Roger A. Rajewski, John L. Haslam, Kathleen Heppert, Michael C. Beckloff, Frank Segrave, Robert Mauro, Peter Colabuono
Assignee:	University of Kansas , Silvergate Pharmaceuticals Inc
Application Number:	US13/914,452
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,778,366
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 8,778,366

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Azurity	EPANED KIT	enalapril maleate	FOR SOLUTION;ORAL	204308-001	Aug 13, 2013		DISCN	Yes	No	8,778,366					TREATMENT OF HYPERTENSION
Azurity	EPANED KIT	enalapril maleate	FOR SOLUTION;ORAL	204308-001	Aug 13, 2013		DISCN	Yes	No	8,778,366					METHOD OF TREATMENT OF HEART FAILURE
Azurity	EPANED KIT	enalapril maleate	FOR SOLUTION;ORAL	204308-001	Aug 13, 2013		DISCN	Yes	No	8,778,366					METHOD OF TREATING HYPERTENSION
Azurity	EPANED KIT	enalapril maleate	FOR SOLUTION;ORAL	204308-001	Aug 13, 2013		DISCN	Yes	No	8,778,366					TREATMENT OF HEART FAILURE

International Family Members for US Patent 8,778,366

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Brazil	112015007592
Canada	2887379
European Patent Office	2903690
Spain	2770403